Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer

01-09-2014 | Case Report

Pure Glycogen-Rich Clear Cell Adenocarcinoma of the Stomach

Author: Tadashi Terada

Published in: Journal of Gastrointestinal Cancer | Issue 3/2014

Login to get access

Excerpt

Glycogen-rich clear cell adenocarcinoma of the stomach is a very rare entity. It is not listed as a histological type in the WHO blue book [1]; however, the book mentions a clear cell variant in one figure. To date, a few reports of this entity have been published [2, 3]. These reports included gastric adenocarcinoma with focal clear cell changes. However, its clinicopathological entity and biological behaviors are not known. In addition, to the best of the author's knowledge, gastric carcinoma composed only of glycogen-rich clear tubular adenocarcinoma has not been reported. The author herein reports a case of early mucosal gastric adenocarcinoma composed only of glycogen-rich clear adenocarcinoma cells. …
Literature
1.
Fenoglio-Preiser C, Munoz N, Carneiro F, et al. Gastric carcinoma. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumour. Pathology and genetics of tumors of the digestive system. Lyon: IARC; 2000. pp. 38–52
2.
Govender D, Ramadial PK, Clarke B, Chetty R. Clear cell (glycogen-rich) gastric adenocarcinoma. Ann Diagn Pathol. 2004;8:69–73.PubMedCrossRef
3.
Ghotli ZA, Serra S, Chetty R. Clear cell (glycogen-rich) gastric adenocarcinoma: a distinct tubulo-papillary variant with a predirection for the cardia/gastroesophageal region. Pathology. 2007;39:466–9.PubMedCrossRef
4.
Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.PubMedCrossRef
5.
Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;206:271–5.PubMedCrossRef
6.
Terada T, Tanigichi M. Intraductal oncocytic papillary neoplasm of the liver. Pathol Int. 2004;54:116–23.PubMedCrossRef
7.
Terada T. Ductal adenoma of the breast: immunohistochemistry of two cases. Pathol Int. 2008;58:801–5.PubMedCrossRef
8.
Terada T. Gallbladder adenocarcinoma arising in Rokitansky-Aschoff sinuses. Pathol Int. 2008;58:806–9.PubMedCrossRef
9.
Terada T. Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Pathol. 2009;28:29–34.PubMedCrossRef
10.
Terada T. Intraductal tubular carcinoma, intestinal type, of the pancreas. Pathol Int. 2009;59:53–8.PubMedCrossRef
11.
Terada T. Large endocervical polyp with cartilaginous and osseous metaplasia: a hitherto unreported entity. Int J Gynecol Pathol. 2009;28:98–100.PubMedCrossRef
12.
Terada T. Small cell neuroendocrine carcinoma of the esophagus: report of 6 cases with immunohistochemical and molecular genetic analysis of KIT and PDGFRA. Int J Clin Exp Pathol. 2013;6:485–91.PubMedCentralPubMed
13.
Terada T. Primary small cell carcinoma of the prostate without immunoreactive neuroendocrine proteins but with expressions of KIT and PDGFRA: a case report with immunohistochemical and molecular genetic analysis. Int J Clin Exp Pathol (in press)
14.
Terada T. Primary small cell carcinoma of the stomach: a case report with an immunohistochemical and molecular genetic analysis. Int J Clin Exp Pathol. 2013;6(3):524–30.PubMedCentralPubMed
15.
Terada T. Expression of NCAM (CD56), chromogranin A, synaptophysin, c-KIT (CD117) and PDGFRA in normal non-neoplastic skin and basal cell carcinoma: an immunohistochemical study of 66 consecutive cases. Med Oncol. 2013;30(1):444.PubMedCrossRef
16.
Terada T. Small cell carcinoma of the oral cavity (cheek mucosa): a case report with an immunohistochemical and molecular genetic analysis. Int J Clin Exp Pathol 2013;6(4)780-7PubMedCentralPubMed
17.
Terada T. Primary small cell carcinoma of the ureter: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA genes. Pathology. 2010;42:101–2.PubMedCrossRef
18.
Terada T. Pulmonary large cell neuroendocrine carcinoma diagnosed in a brain metastasis. Int J Clin Exp Pathol. 2012;5:159–62.PubMed
19.
Terada T. Small cell carcinoma of the prostate. Int J Clin Exp Pathol (in press)
20.
Terada T. Small cell carcinoma of the brain without extracranial involvement by serial CT, MRI and PET. Int J Clin Exp Pathol. 2010;3:323–7.PubMedCentralPubMed
21.
Terada T. Bronchial atypical carcinoid tumor without invasion but with marked intraluminal growth like branchial tree cast. Respir Med. 2010;3:179–82.
22.
Terada T. Primary small cell carcinoma of the pleura: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol. 2010;27:1119–22.PubMedCrossRef
23.
Terada T. KIT-positive primary small cell carcinoma of the endometrium: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Arch Gynecol Obstet. 2010;282:413–6.PubMedCrossRef
24.
Terada T. Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA. Pathol Res Pract. 2010;206:420–5.PubMedCrossRef
25.
Terada T. Composite carcinoid and small cell carcinoma of the duodenum. Scand J Gastroenterol. 2010;45:1387–92.PubMedCrossRef
26.
Terada T. Carcinoid tumors of digestive organs: a clinicopathologic study of 13 cases. Gastroenterol Res. 2009;2:35–7.
27.
Terada T. Primary small cell carcinoma of the mediastinum: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol. 2009;26:247–50.PubMedCrossRef
28.
Terada T. Autopsy case of primary small cell carcinoma of the urinary bladder: KIT and PDGFRA expression and mutations. Pathol Int. 2009;59:247–50.PubMedCrossRef
29.
Terada T, Maruo H. Primary combined carcinoma of the esophagus: immunohistochemical and molecular genetic studies. World J Gastroenterol. 2012;18:1545–51.PubMedCentralPubMedCrossRef
30.
Terada T. An immunohistochemical and molecular genetic analysis of KIT and PDGFRA in small cell lung carcinoma in Japanese. Int J Clin Exp Pathol. 2012;5(4):331–8.PubMedCentralPubMed
31.
Terada T. Primary combined adenoid cystic carcinoma, basaloid squamous cell carcinoma and squamous cell carcinoma of the esophagus. Endoscopy. 2012;44(Suppl 2):E102–E103. doi:10.​1055/​s-0030-1256794
32.
Terada T. Primary small cell carcinoma of the maxillary sinus: a case report with immunohistochemical and molecular genetic study involving KIT and PDGFRA. Int J Clin Exp Pathol. 2012;5:264–9.PubMedCentralPubMed
33.
Terada T. Primary esophageal small cell carcinoma with brain metastasis and with CD56, KIT, and PDGFRA expressions. Pathol Oncol Res. 2012;18:1091–3.PubMedCrossRef
34.
35.
Terada T. Small cell carcinoma of the ileum that developed 10 years after total gastrectomy for gastric signet ring cell carcinoma. Appl Immunohistochem Mol Morphol. 2012;20:618–9.PubMedCrossRef
36.
Terada T. Small cell neuroendocrine carcinoma of the prostate: incidence and a report of four cases with an examination of KIT and PDGFRA. Prostate. 2012;72:1150–6.PubMedCrossRef
37.
Terada T. Neuroendocrine carcinoma of the esophagus: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA. Med Oncol. 2011;28:509–12.PubMedCrossRef
38.
39.
40.
Terada T. Primary signet-ring cell carcinoma of the pancreas diagnosed by endoscopic retrograde pancreatic duct biopsy: a case report with an immunohistochemical study. Endoscopy. 2012;44(Suppl 2):UCTN:E141-2. doi:10.​1055/​s-0030-1257045
41.
Terada T. Primary pure signet ring cell adenocarcinoma of the non-Barrett’s esophagus: a case report with immunohistochemical study. Endoscopy 2011;43: E397-8
42.
Terada T. Ovarian malignant Mullerian mixed tumor (heterologous) whose epithelial component is composed predominantly of signet ring cell carcinoma. Arch Gynecol Obstet. 2011;283:1403–6.PubMedCrossRef
43.
44.
Terada T. Primary pure signet-ring cell adenocarcinoma of the urinary bladder: a report of three cases with an immunohistochemical study. Med Oncol. 2012;29(4):2866–9.PubMedCrossRef
45.
Terada T. Primary signet-ring cell carcinoma of the lung: a case report with an immunohistochemical study. Int J Clin Exp Pathol. 2012;5:171–4.PubMed
46.
47.
Terada T. Signet-ring cell carcinoma of the non-ampullary duodenum and proximal jejunum: a case report with an immunohistochemical study. Endoscopy. (in press)
48.
Terada T. Primary signet-ring cell carcinoma of the vermiform appendix clinically and pathologically presenting as acute appendicitis: a case report with immunohistochemical study. Int J Clin Exp Pathol (in press)
49.
Terada T. Primary pure signet-ring cell carcinoma of the vermiform appendix presenting as bilateral ovarian huge tumors (Krukenberg tumor): a case report with immunohistochemical study. Int J Clin Exp Pathol (in press)
50.
Terada T. Primary pure signet-ring cell carcinoma of the anus: a case report with immunohistochemical study. Endoscopy. (in press)
51.
Terada T. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases. Int J Clin Exp Pathol 2013;6(4):703-10
52.
Terada T. Primary signet-ring cell carcinoma of the ampulla of Vater: a case report with an immunohistochemical study. Appl Immunohistochem Mol Morphol. 2012;20:427–8.PubMedCrossRef
53.
Terada T. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases. Int J Clin Exp Pathol 2013;6(4):613-21
54.
Terada T. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases. Int J Clin Exp Pathol 2013;6(4):630-8
55.
Terada T. Clear cell variant of ductal carcinoma in situ of the breast. Breast J. 2012;18(3):279–80.PubMedCrossRef
56.
Terada T. Clear cell adenocarcinoma of the ovary arising in atypical endometriosis: a report of 8 cases. Arch Gynecol Obstet. 2012;285(1):229–33.PubMedCrossRef
57.
Terada T. Clear cell adenocarcinoma of the uterine cervix in a young pregnant woman: a case report with immunohistochemical study. Medical Oncology. 2011;28:290–3.PubMedCrossRef
58.
Terada T. Nested variant of urothelial carcinoma of the urinary bladder: report of two cases. Rare Tumors. 2011;3(4):e42.PubMedCentralPubMed
59.
Terada T, Ikeuchi S, Inomoto C, Shimamura K. Mucoepidermoid carcinoma of the palate composed exclusively of clear cells (clear cell variant). Virchows Archiv. 2004;445:541–3.PubMedCrossRef
60.
61.
Terada T. Protein expression and gene mutation status of KIT and PDGFRA in renal cell carcinoma. Histol Histopathol. 2012;27:297–302.PubMed
Metadata
Title
Pure Glycogen-Rich Clear Cell Adenocarcinoma of the Stomach
Author
Tadashi Terada
Publication date
01-09-2014
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2014
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-013-9482-x
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits